Associated with A Glucocorticoid Bridging Scheme, Methotrexate is as Effective Alone as in Combination with Other DMARDS for Early Rheumatoid Arthritis, with Fewer Reported Side Effects: 16 Weeks Remission Induction Data from the Carera Trial

Verschueren, Patrick; De Cock, Diederik; Johan, Joly; Van der Elst, Kristien; Meyfroidt, Sabrina; Westhovens, Rene

doi:10.1136/annrheumdis-2014-eular.2137

Ann Rheum Dis 2014

Associated with A Glucocorticoid Bridging Scheme, Methotrexate is as Effective Alone as in Combination with Other DMARDS for Early Rheumatoid Arthritis, with Fewer Reported Side Effects: 16 Weeks Remission Induction Data from the Carera Trial

Author:

Verschueren, Patrick

De Cock, Diederik ; Johan, Joly ; Van der Elst, Kristien ; Meyfroidt, Sabrina ; Westhovens, Rene

Keywords:

Science & Technology, Life Sciences & Biomedicine, Rheumatology, 1103 Clinical Sciences, 1107 Immunology, 1117 Public Health and Health Services, Arthritis & Rheumatology, 3202 Clinical sciences, 3204 Immunology

Ann Rheum Dis 2014 Associated with A Glucocorticoid Bridging Scheme, Methotrexate is as Effective Alone as in Combination with Other DMARDS for Early Rheumatoid Arthritis, with Fewer Reported Side Effects: 16 Weeks Remission Induction Data from the Carera Trial

Author:

Keywords:

Ann Rheum Dis 2014

Associated with A Glucocorticoid Bridging Scheme, Methotrexate is as Effective Alone as in Combination with Other DMARDS for Early Rheumatoid Arthritis, with Fewer Reported Side Effects: 16 Weeks Remission Induction Data from the Carera Trial